TGFB1 and age-related macular degeneration: Recently, a specific impairment of the TGF-β1 signaling pathway has been demonstrated in Alzheimer’s disease (AD), an amyloid-related neurodegenerative disorder, that shares similar features with age-related macular degeneration (AMD) [6,7,8].